There are more diseases that mimic multiple sclerosis than most people realize — and if you have ever sat across from a doctor and walked away with a diagnosis that didn’t quite fit, or watched a previous diagnosis quietly disappear as a new one took its place, you already know how disorienting this road can be.

I’ve lived it. Years ago, before my MS diagnosis, I was told my symptoms were anxiety. Not a legitimate neurological condition that deserved investigation. Just anxiety. The implication being that if I could just worry less about my health, I’d feel better. I wasn’t anxious about my health. I was sick. There’s a difference, and it took years for anyone to believe me. If you’ve experienced something similar, you’re not alone — medical gaslighting is one of the most common and painful parts of the chronic illness journey.

And even once I was finally being taken seriously, the first neurologist I saw dismissed what I was experiencing as migraines. Not MS. Just migraines. It wasn’t until I sought out an MS specialist that the real picture finally started to come into focus.

After my MS diagnosis, I was diagnosed with yet another condition that had been quietly running alongside it the whole time. So when I say that getting to the right diagnosis is like solving a puzzle with missing pieces, I mean it, because I’ve been that puzzle.

The frustrating truth is that multiple sclerosis doesn’t exist in a vacuum. There are more than a dozen conditions that can look almost identical to MS, sharing its symptoms, mimicking its patterns on imaging, and sending both patients and physicians down the wrong path. For some people, the misdiagnosis lasts months. For others, years.

This article walks through 14 of those conditions, what they are, how they overlap with MS, and what sets them apart. My hope is that if you’re in the middle of that confusing, exhausting search for answers, this gives you something useful to bring to your next appointment.

Key Takeaways

• At least 14 conditions share symptoms with MS, making accurate diagnosis genuinely difficult even for experienced physicians.
• Misdiagnosis before an MS diagnosis is common — you are not alone if your path to answers has been long and frustrating.
• Some MS mimics are caused by nutritional deficiencies, infections, or vascular damage rather than autoimmune activity, and may be reversible with treatment.
• MRI findings are one of the most important tools for distinguishing MS from conditions that look like it, but not all mimics show up the same way on imaging.
• A correct diagnosis often requires a team of specialists, not just a single physician.
• Advocating for yourself, seeking second opinions, and asking for specialist referrals can make a significant difference in getting to the right answer.

14 Diseases that Mimic Multiple Sclerosis: A Quick Reference

Before we dive into each condition in detail, here is a quick overview of all 14 so you can see at a glance how they compare to MS. We will explore each one more fully below, including symptoms, key differences, and the specialists involved in diagnosis and treatmen

Vitamin B12 Deficiency

Vitamin B12 deficiency occurs when the body doesn’t have enough of this essential vitamin to support normal brain and nervous system function, or to produce healthy red blood cells. I know this one personally — I have had to go through multiple rounds of B12 injections because my levels kept dropping. The frustrating part was that even after my levels normalized, I didn’t notice much improvement. It took time to understand that what I was still experiencing wasn’t B12 deficiency at all. It was the underlying MS that had been there all along.

What Causes Vitamin B12 Deficiency?

Vitamin B12 deficiency can be caused by a variety of factors including:

• Poor dietary intake, particularly in vegetarians and vegans
• Gastrointestinal disorders that interfere with absorption, such as Crohn’s disease or celiac disease
• Certain medications, including proton pump inhibitors and metformin
• Pernicious anemia, an autoimmune condition that affects B12 absorption

Symptoms of Vitamin B12 Deficiency

• Fatigue and weakness
• Numbness or tingling in the hands and feet
• Difficulty walking or balance problems
• Memory problems or confusion
• Depression or other mood changes
• Anemia (too few healthy red blood cells)
• Pale or yellowish skin
• Sore, red tongue or mouth ulcers
• Digestive problems such as diarrhea or constipation
• Vision loss
• Shortness of breath

How Vitamin B12 Deficiency Mimics MS

The overlap between B12 deficiency and MS is significant enough that neurologists routinely test B12 levels as part of the MS diagnostic workup. Both conditions can cause numbness and tingling in the limbs, fatigue, balance problems, cognitive difficulties, mood changes, and even changes on MRI. In severe cases, B12 deficiency can cause damage to the spinal cord that produces symptoms nearly identical to those of MS.

Key Differences Between Vitamin B12 Deficiency and MS

• Cause: B12 deficiency is caused by inadequate levels of a specific vitamin, not an autoimmune attack on the nervous system.
• Reversibility: Unlike MS, B12 deficiency is often reversible with treatment. Restoring B12 levels through diet, supplements, or injections can improve or resolve symptoms, particularly when caught early.
• Diagnosis: A simple blood test can confirm B12 deficiency. MS requires a much more comprehensive workup including MRI, neurological examination, and often spinal fluid analysis.
• Progression: MS is a progressive condition. B12 deficiency, if untreated, can worsen over time but does not follow the relapsing-remitting or progressive pattern seen in MS.

Diagnosis and Treatment

Diagnosis is straightforward — a blood test measuring B12 levels is usually sufficient. Treatment typically involves increasing B12 intake through diet or oral supplements. In more severe cases, or when absorption is the underlying problem, a course of B12 injections may be necessary. It is important to seek medical advice if you suspect you may be deficient, as untreated B12 deficiency can cause permanent neurological damage over time.

Treatment Team

• Primary Care Physicians: Usually the first to identify and treat B12 deficiency through routine blood work.
• Neurologists: Involved when neurological symptoms are present, to rule out MS and other conditions.
• Gastroenterologists: If a digestive condition such as Crohn’s disease or celiac disease is affecting absorption.
• Hematologists: If anemia associated with B12 deficiency requires specialist management.

Learn more at the NIH Office of Dietary Supplements: Vitamin B12 Fact Sheet.

Lyme Disease

Sarcoidosis is a systemic inflammatory disease that affects multiple organs in the body, most commonly the lungs and lymph nodes. It is characterized by the formation of granulomas — small clumps of inflammatory cells — in affected tissues. The exact cause is unknown, but it is thought to be related to an abnormal immune response.

Sarcoidosis is one of those conditions that rarely comes up in conversation, yet it lands on this list because when it affects the nervous system, it can look remarkably like MS. If you have ever been told you might have sarcoidosis, or had it mentioned during your diagnostic workup, here is what you need to know.

Symptoms of Sarcoidosis

Symptoms can vary widely depending on which organs are affected and may include:

• Fatigue
• Shortness of breath
• Cough
• Chest pain
• Skin rashes or lesions
• Swollen lymph nodes
• Joint pain and stiffness
• Fever
• Weight loss

Many people with sarcoidosis have only mild symptoms or none at all and are able to live normal lives. However, in some cases it can cause serious complications such as heart or lung damage.

How Sarcoidosis Mimics MS

When sarcoidosis affects the nervous system — a condition called neurosarcoidosis — it can produce symptoms that closely resemble MS. Both conditions can cause neurological symptoms such as headache, facial paralysis, and vision problems, as well as fatigue and a relapsing-remitting course with periods of flare and remission. Both can also show abnormalities on MRI, which is one of the reasons sarcoidosis is sometimes misdiagnosed as MS, or vice versa.

Key Differences Between Sarcoidosis and MS

• Cause: Sarcoidosis is caused by the formation of granulomas — clusters of inflammatory cells — in tissues throughout the body. MS is caused by an autoimmune attack on myelin, the protective sheath surrounding nerve fibers in the central nervous system.
• Organ impact: Sarcoidosis can affect multiple organs including the lungs, lymph nodes, skin, eyes, and heart. MS primarily affects the brain, spinal cord, and optic nerves.
• Imaging findings: MRI in sarcoidosis typically shows granulomas in affected tissues. In MS, MRI shows myelin loss and lesions in the central nervous system, with a characteristic pattern and distribution.
• Symptoms: Sarcoidosis symptoms vary based on which organs are affected and often include respiratory and skin involvement. MS symptoms are primarily neurological.
• Treatment: Sarcoidosis is treated with anti-inflammatory and immunosuppressive medications including corticosteroids, immunosuppressants, and biologics. MS is treated with disease-modifying therapies aimed at slowing progression and reducing relapses.

Diagnosis

Diagnosis of sarcoidosis typically involves a combination of imaging tests such as chest X-rays or CT scans, blood tests, and in many cases a biopsy of affected tissue to confirm the presence of granulomas. Treatment may not be necessary for mild cases, but more severe cases require medications to reduce inflammation and suppress the immune system.

Treatment Team

• Pulmonologists: Lung and respiratory specialists, as the lungs are the most commonly affected organ.
• Rheumatologists: For managing joint, muscle, and connective tissue involvement.
• Dermatologists: Skin specialists, as sarcoidosis frequently affects the skin.
• Ophthalmologists: Eye doctors, as sarcoidosis can affect vision and eye health.
• Neurologists: When sarcoidosis affects the nervous system.
• Infectious Disease Specialists: To help rule out infections with similar presentations.
• Primary Care Physicians: Often the first to identify symptoms and coordinate specialist care.

Learn more at the Foundation for Sarcoidosis Research.

Primary Progressive Aphasia (PPA) is a rare neurodegenerative disorder that primarily affects language and communication abilities. It typically affects people in their 50s and 60s, although it can occur at any age.

PPA is one of the less obvious entries on this list — it is not a condition most people connect to MS at first glance. But when you look at how both conditions can affect cognitive function and show up on brain imaging, the overlap becomes clear. If you or someone you love has been experiencing unexplained changes in language or communication, this is worth understanding. PPA is caused by the progressive degeneration of brain cells responsible for language and communication functions, and there is currently no cure, though the rate of progression varies significantly from person to person.

The Three Subtypes of PPA

PPA is not a single uniform condition. There are three distinct subtypes, each affecting language in a different way:

• Semantic variant PPA: Primarily affects word comprehension and object recognition. People with this subtype may struggle to find the right words or names for objects and people.
• Agrammatic (non-fluent) variant PPA: Affects grammar and sentence structure, resulting in effortful, halting speech and difficulty constructing sentences correctly.
• Logopenic variant PPA: Affects word finding and word repetition. People with this subtype may speak slowly and hesitantly, and have difficulty recalling specific words mid-sentence.

Despite their differences, all three subtypes share some common features. Language is the primary function affected, while other cognitive abilities such as memory, attention, and spatial awareness are often preserved in the early stages. All subtypes are progressive, and all can cause significant emotional distress for both the individual and their loved ones.

How PPA Mimics MS

Both PPA and MS can cause cognitive difficulties and communication problems, and both can show abnormalities on MRI. In the early stages, the language and cognitive changes seen in PPA can overlap with the cognitive impairment sometimes associated with MS, leading to potential confusion during diagnosis. Both conditions can also cause emotional and psychological distress, including depression and anxiety.

Key Differences Between PPA and MS

• Primary symptom: PPA is defined by a progressive loss of language abilities — difficulty finding words, making grammatical errors, and trouble with comprehension. While MS can cause cognitive difficulties, it does not cause this specific and isolated deterioration of language function.
• Cause: PPA is caused by the degeneration of brain cells in the language areas of the brain. MS is caused by an autoimmune attack on myelin, the protective sheath surrounding nerve fibers.
• Imaging findings: MRI in PPA typically shows atrophy, or shrinkage, in the language areas of the brain. In MS, MRI shows lesions in the brain and spinal cord rather than atrophy.
• Progression: PPA progresses steadily over time with no periods of remission. MS can follow a relapsing-remitting course with periods of recovery between relapses.
• Treatment: There is no cure for PPA, but speech and language therapy can help slow the progression of symptoms and improve communication. MS is treated with disease-modifying therapies aimed at reducing inflammation and slowing disease progression.

Diagnosis

Diagnosing PPA requires a comprehensive evaluation that includes neurological examination, neuropsychological testing to assess language and cognitive function, and MRI imaging to identify patterns of brain atrophy. Because PPA is rare and its early symptoms can be subtle, it is often diagnosed by specialists with specific expertise in neurodegenerative conditions.

Treatment Team

• Neurologists: The primary specialists for diagnosing and managing PPA and ruling out other neurological conditions.
• Speech-Language Pathologists: Essential members of the care team who provide therapy to help maintain communication abilities for as long as possible.
• Neuropsychologists: Specialists in cognitive and psychological assessment who can provide detailed diagnostic information about language and other cognitive functions.
• Psychiatrists: For managing depression, anxiety, and other mental health conditions that frequently accompany PPA.
• Primary Care Physicians: Often the first to notice changes in language or communication and initiate the referral process.

Learn more at the Association for Frontotemporal Degeneration: Primary Progressive Aphasia.

Cerebral Small Vessel Disease (CSVD) is a neurological condition characterized by damage to the small blood vessels in the brain. It can be caused by a variety of factors including high blood pressure, diabetes, smoking, and aging. This damage can lead to cognitive impairment, memory loss, difficulty with balance and coordination, and in some cases stroke. CSVD is also associated with an increased risk of developing dementia. Types of CSVD include leukoaraiosis, lacunar infarcts, microbleeds, and white matter hyperintensities.

Symptoms of Cerebral Small Vessel Disease

Symptoms can vary depending on the severity and location of the damage, and may include:

• Cognitive impairment, including problems with memory, attention, and executive function
• Weakness, numbness, and other motor problems
• Difficulty with balance and coordination
• Mood and personality changes, including depression, anxiety, and apathy
• Visual disturbances, such as double vision or loss of vision in one eye
• Headaches, which may be severe and frequent
• Fatigue
• Urinary incontinence or difficulty emptying the bladder

Some people with CSVD experience only mild symptoms, while others experience more severe and disabling ones. It is important to see a healthcare provider if you notice any of these symptoms, especially if they are new or worsening over time.

How CSVD Mimics MS

CSVD and MS share enough overlapping symptoms to make diagnosis genuinely challenging, particularly when white matter changes appear on MRI. Both conditions can cause cognitive impairment, weakness, numbness, balance problems, visual disturbances, and emotional and psychological changes including depression and anxiety. Both can also follow a course where symptoms come and go over time. The white matter changes that CSVD produces on MRI are one of the most significant sources of confusion between the two conditions, as they can closely resemble the lesions seen in MS.

Key Differences Between CSVD and MS

• Cause: CSVD is caused by damage to the small blood vessels in the brain, typically related to vascular risk factors such as high blood pressure, diabetes, smoking, and aging. MS is an autoimmune disorder in which the immune system attacks the myelin sheath surrounding nerve fibers.
• Symptom pattern: MS is more likely to cause muscle weakness, tremors, and vision problems. CSVD is more likely to cause cognitive impairment, gait disturbance, and urinary incontinence.
• Imaging findings: In MS, MRI shows lesions in the brain and spinal cord with a characteristic pattern and distribution. In CSVD, MRI shows white matter changes and small infarcts that have a different appearance and location from MS lesions.
• Age of onset: MS is more commonly diagnosed in younger adults, often in their 20s and 30s. CSVD is more common in older adults and is strongly associated with age-related vascular risk factors.
• Treatment: MS is treated with disease-modifying therapies aimed at reducing inflammation and slowing progression. CSVD is managed by controlling the underlying vascular risk factors through medication, lifestyle changes, and in some cases antiplatelet agents.

Diagnosis

Diagnosis of CSVD typically involves MRI or CT imaging to reveal the extent of damage to the brain’s small blood vessels. Managing underlying risk factors is central to treatment, and may include medication to control blood pressure or diabetes, lifestyle changes such as quitting smoking and increasing physical activity, and rehabilitation or physical therapy to improve balance and coordination.

Treatment Team

• Neurologists: The primary specialists for diagnosing and managing CSVD.
• Cardiologists: For managing cardiovascular risk factors such as high blood pressure.
• Endocrinologists: For managing diabetes, which is a common contributing factor.
• Physical Therapists: To help improve balance, coordination, and mobility.
• Primary Care Physicians: Often the first to identify vascular risk factors and coordinate care across specialties.

Learn more at the National Institute of Neurological Disorders and Stroke: Cerebrovascular Disease.

Lupus, also known as systemic lupus erythematosus (SLE), is a chronic autoimmune disease that can affect various parts of the body, including the skin, joints, kidneys, heart, lungs, and brain. In lupus, the immune system mistakenly attacks the body’s own tissues, causing inflammation and damage. The exact cause of lupus is unknown, but it is believed to be a combination of genetic and environmental factors. Women are more likely to develop lupus than men, and it often appears during childbearing years. If you want to understand more about what it’s like to live with an autoimmune disease, I’ve written about that experience in depth.

Symptoms of Lupus

Symptoms can vary from person to person and can come and go over time. Common symptoms include:

• Extreme fatigue
• Joint pain, stiffness, and swelling
• Butterfly-shaped rash across the cheeks and nose
• Discoid rash — red, raised, scaly patches on the skin
• Sensitivity to sunlight
• Chest pain, especially when breathing deeply or coughing
• Fever, particularly during flare-ups
• Hair loss or thinning
• Mouth or nose sores
• Swelling in the hands, feet, legs, and around the eyes
• Raynaud’s phenomenon — fingers and toes turning white or blue in response to cold or stress

It is important to see a healthcare provider if you experience any of these symptoms, especially if they are new or worsening. Early diagnosis and treatment can help manage symptoms and prevent complications.

How Lupus Mimics MS

Lupus and MS are both autoimmune diseases in which the immune system mistakenly attacks the body’s own tissues. Both conditions can cause fatigue, cognitive problems such as memory loss and difficulty concentrating, neurological symptoms including tingling and numbness in the limbs, and mood disorders such as depression and anxiety. This overlap in symptoms is one of the reasons lupus is sometimes mistaken for MS, particularly in the early stages of either condition.

Key Differences Between Lupus and MS

• Target organs: Lupus primarily affects the skin, joints, and kidneys, while MS primarily affects the brain and spinal cord.
• Distinctive symptoms: The butterfly-shaped facial rash is a hallmark of lupus and does not occur in MS. MS is more likely to cause muscle weakness, tremors, and vision problems.
• Imaging findings: MRI scans in MS typically show lesions in the brain and spinal cord. In lupus, MRI may show inflammation-related changes but not the same pattern of lesions seen in MS.
• Progression: Lupus can have periods of remission and flare-ups, while MS is a progressive disease that can lead to permanent disability over time.
• Treatment: Lupus is typically treated with anti-inflammatory medications, antimalarial drugs, and immunosuppressive agents. MS is treated with disease-modifying therapies aimed at slowing progression and reducing relapses.

Diagnosis

Lupus is typically diagnosed through a combination of physical examination, blood tests including an ANA (antinuclear antibody) panel, and imaging studies. Because lupus can affect so many different organ systems, diagnosis often involves a team of specialists working together.

Treatment Team

• Rheumatologists: The primary specialists for lupus diagnosis and management.
• Nephrologists: Kidney specialists, as lupus commonly affects the kidneys.
• Dermatologists: Skin specialists, as lupus frequently causes skin rashes and lesions.
• Cardiologists: Heart specialists, as lupus can affect the heart and cardiovascular system.
• Neurologists: For cases where lupus affects the nervous system.
• Primary Care Physicians: Often the first to identify symptoms and coordinate care across specialties.

Learn more at the Lupus Foundation of America.

Neuromyelitis optica (NMO), also known as Devic’s disease, is a rare autoimmune disorder of the central nervous system that I had never heard of before I started researching this article. And honestly, that surprised me — especially when I learned what NMO actually looks like.

About a year before my MS diagnosis, I ended up in the emergency room after suddenly going nearly blind in one eye. At the time, no one connected it to anything larger. Looking back, it was almost certainly optic neuritis, which is one of the hallmark symptoms of both NMO and MS. I didn’t know that then. I just knew something was very wrong. NMO primarily affects the optic nerves and spinal cord, causing inflammation and damage that can lead to blindness, weakness, numbness, and paralysis — and it mimics MS so closely that for years, many people with NMO were simply diagnosed with MS instead. Early diagnosis and treatment are critical, as NMO can cause significant and permanent damage to the nervous system if left untreated.

• Optic neuritis: Inflammation of the optic nerve causing blurred vision, loss of vision, and pain behind the eyes
• Transverse myelitis: Inflammation of the spinal cord causing weakness, numbness, or tingling in the arms and legs, which can progress to paralysis
• Nausea, vomiting, and hiccups, when NMO affects the area of the brain controlling these functions
• Severe pain in the back, arms, legs, or abdomen
• Fatigue, even after adequate rest
• Bladder and bowel problems, including urinary incontinence, constipation, or diarrhea
• Difficulty speaking or swallowing

If you are experiencing any of these symptoms, it is important to see a doctor as soon as possible.

How NMO Mimics MS

NMO is one of the closest mimics of MS in existence — so close that before the discovery of the AQP4 antibody, many people with NMO were simply diagnosed with MS. Both are autoimmune disorders that attack the central nervous system. Both can cause optic neuritis, weakness, numbness, tingling, loss of balance, and cognitive impairment. Both can follow a relapsing-remitting course. Both are treated with immunomodulatory medications. This level of overlap makes NMO one of the most important conditions to rule out when MS is suspected.

Key Differences Between NMO and MS

• Antibodies: NMO is associated with antibodies against aquaporin-4 (AQP4), a protein found on the surface of cells in the central nervous system. MS involves antibodies against myelin basic protein and other myelin components. A blood test for AQP4 antibodies is now a standard part of distinguishing NMO from MS.
• Lesion location: NMO lesions are concentrated in the optic nerves and spinal cord. MS lesions can appear throughout the central nervous system, including the brain, spinal cord, and optic nerves.
• Severity of attacks: NMO attacks tend to be more severe and cause more permanent damage than typical MS relapses. MS relapses are often more frequent but less catastrophic.
• Prognosis: NMO carries a higher risk of severe disability than MS, particularly when diagnosis and treatment are delayed.
• Treatment: While there is some overlap, NMO has specific treatments such as rituximab and eculizumab that are not typically used in MS. Some MS treatments can actually worsen NMO, making an accurate diagnosis critical.

Diagnosis

Diagnosis of NMO involves blood testing for AQP4 antibodies, MRI imaging to identify the location and pattern of lesions, and spinal fluid analysis. The discovery of the AQP4 antibody has been a major breakthrough in distinguishing NMO from MS, and testing for it is now a routine part of the diagnostic process for anyone presenting with MS-like symptoms.

Treatment Team

• Neurologists: The primary specialists for NMO diagnosis and management, ideally with experience in demyelinating diseases.
• Ophthalmologists: For managing optic neuritis and monitoring vision.
• Urologists: For managing bladder dysfunction, which is common in NMO.
• Physical and Occupational Therapists: To help maintain mobility and function following attacks.
• Primary Care Physicians: For coordinating care across specialties and managing general health.

Learn more at the National MS Society: Neuromyelitis Optica.

Copper deficiency is a condition that occurs when the body doesn’t get enough copper, an essential mineral that plays an important role in many physiological processes. Copper is necessary for the formation of red blood cells and connective tissue, and for various enzymes involved in energy production, iron metabolism, and antioxidant defense.

This one caught my attention during my own research because copper deficiency was something I actually wondered about for myself. When your neurological symptoms don’t have a clear explanation yet, you find yourself looking at everything — and copper deficiency is worth looking at. It is more common than most people realize, and because it can affect myelin the same way MS does, it belongs on this list. In severe cases, copper deficiency can lead to a condition called Menkes disease, a genetic disorder that affects copper absorption and transport in the body.

What Causes Copper Deficiency?

Copper deficiency can result from a variety of factors including:

• Inadequate dietary intake
• Malabsorption disorders
• Excessive zinc intake, which can interfere with copper absorption
• Certain medical conditions such as cystic fibrosis and Wilson’s disease

Treatment involves copper supplementation and addressing the underlying cause of the deficiency. It is important that supplementation be done under the guidance of a healthcare professional, as excessive copper intake can also cause adverse health effects.

Symptoms of Copper Deficiency

• Fatigue and weakness
• Anemia, leading to shortness of breath and pale skin
• Numbness, tingling, or weakness in the arms and legs
• Difficulty walking and balance problems
• Problems with memory and thinking
• Bone and joint problems such as osteoporosis or osteoarthritis
• Pale skin or hair, or patches of depigmentation
• Impaired immune function and increased susceptibility to infections
• Vision problems including optic neuritis

How Copper Deficiency Mimics MS

Copper deficiency is one of the more surprising MS mimics because it can affect myelin — the same protective sheath that MS attacks. When copper levels are insufficient, the body cannot properly form or maintain myelin, which leads to neurological symptoms that closely resemble those of MS. Both conditions can cause numbness and tingling in the limbs, fatigue, balance problems, difficulty walking, vision problems, and cognitive impairment. In some cases, copper deficiency has even produced MRI findings that initially appeared consistent with MS.

Key Differences Between Copper Deficiency and MS

• Cause: Copper deficiency is caused by inadequate copper levels in the body due to diet, malabsorption, or other factors. MS is an autoimmune disorder in which the immune system attacks the myelin sheath surrounding nerve fibers.
• Reversibility: Copper deficiency is generally reversible with treatment. Restoring copper levels can improve or resolve neurological symptoms, particularly when caught early. MS is a chronic, progressive condition with no cure.
• Additional symptoms: Copper deficiency can cause anemia, bone and joint problems, and skin and hair changes that are not features of MS.
• Diagnosis: Copper deficiency is diagnosed through blood tests measuring copper and ceruloplasmin levels. MS requires a much more comprehensive workup including MRI, neurological examination, and often spinal fluid analysis.
• Treatment: Copper deficiency is treated with copper supplementation and dietary changes. MS is treated with disease-modifying therapies targeting the immune system.

Diagnosis

A simple blood test measuring copper and ceruloplasmin levels is usually sufficient to diagnose copper deficiency. Because the neurological symptoms can so closely resemble MS, copper levels are routinely checked as part of the MS diagnostic workup. If you are experiencing neurological symptoms, it is worth asking your doctor to check your copper levels before assuming a diagnosis.

Treatment Team

• Primary Care Physicians: Often the first to identify copper deficiency through routine blood work and to initiate supplementation.
• Neurologists: Involved when neurological symptoms are present, to rule out MS and other conditions.
• Gastroenterologists: If a digestive or malabsorption condition is affecting copper absorption.
• Hematologists: If anemia associated with copper deficiency requires specialist management.

Learn more at the NIH Office of Dietary Supplements: Copper Fact Sheet.

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord that control voluntary muscle movement. The disease causes the death of motor neurons, leading to muscle weakness, twitching, and ultimately paralysis. As ALS progresses, individuals may experience difficulty breathing, speaking, and swallowing. The exact cause of ALS is unknown, but it is thought to be a combination of genetic and environmental factors. There is currently no cure, but medications and therapies can help manage symptoms and improve quality of life. Research is ongoing to develop new treatments.

Symptoms of ALS

• Muscle weakness, often beginning in the limbs or the muscles controlling speech, swallowing, or breathing
• Muscle wasting, including thinning of the arms and legs as the disease progresses
• Spasticity — muscle stiffness that can make movement difficult or painful
• Muscle twitching or cramping, particularly in the arms and legs
• Slurred speech and difficulty swallowing
• Breathing difficulties, which can progress to respiratory failure
• Extreme fatigue

How ALS Mimics MS

ALS and MS can look similar in their early stages, particularly when muscle weakness, fatigue, and difficulty with coordination are the presenting symptoms. Both are serious neurological conditions that affect the brain and spinal cord, and both can cause progressive physical disability. In the early stages of ALS, before the characteristic pattern of rapid motor neuron loss becomes clear, the overlap with MS can cause diagnostic uncertainty.

Key Differences Between ALS and MS

• Underlying cause: ALS is caused by the progressive degeneration of motor neurons. MS is an autoimmune disorder caused by damage to the myelin sheath surrounding nerve fibers.
• What is affected: ALS exclusively affects motor neurons — the nerve cells responsible for voluntary muscle movement. MS affects sensation, movement, coordination, vision, and cognition across a broader range of neurological functions.
• Course of disease: ALS is rapidly progressive and typically leads to severe disability and death within a few years of diagnosis. MS has a much more variable course and often includes periods of remission.
• Sensory symptoms: MS commonly causes numbness, tingling, and other sensory disturbances. ALS primarily affects motor function and does not typically cause sensory symptoms.
• Age of onset: ALS usually occurs in middle age or later. MS is more commonly diagnosed in young adults.
• Treatment: ALS treatment focuses on symptom management and supportive care. MS can be treated with disease-modifying therapies that slow progression and reduce relapses.

Diagnosis

ALS is diagnosed through a combination of clinical evaluation, electromyography (EMG), nerve conduction studies, and MRI to rule out other conditions. Because there is no single definitive test for ALS, diagnosis often involves ruling out other neurological conditions including MS. Early diagnosis is important as it allows patients to access supportive therapies and make informed decisions about their care.

Treatment Team

• Neurologists: The primary specialists for ALS diagnosis and management.
• Pulmonologists: For managing breathing difficulties as the disease progresses.
• Speech-Language Pathologists: For managing communication and swallowing difficulties.
• Physical and Occupational Therapists: To help maintain mobility, function, and independence for as long as possible.
• Palliative Care Specialists: To support quality of life and manage symptoms throughout the course of the disease.
• Primary Care Physicians: For coordinating care across the multidisciplinary team.

Learn more at the ALS Association.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder that affects the peripheral nerves — the nerves that control movement and sensation outside of the brain and spinal cord. In CIDP, the immune system mistakenly attacks and damages the myelin sheath that surrounds and insulates these nerves, resulting in nerve dysfunction. CIDP develops slowly over time and can last for years. In severe cases it can lead to permanent nerve damage and disability, but early diagnosis and treatment can significantly improve outcomes.

Symptoms of CIDP

• Muscle weakness in the arms and legs, often beginning mildly and gradually worsening
• Numbness, tingling, and other abnormal sensations in the hands and feet
• Difficulty with balance and coordination
• Fatigue
• Pain that may be described as aching, burning, or shooting
• Loss of reflexes, especially in the ankles
• Muscle cramps and spasms
• Breathing difficulties in rare, severe cases

How CIDP Mimics MS

CIDP and MS share a fundamental mechanism — both involve demyelination, the damage or destruction of the myelin sheath that surrounds nerve fibers. This common mechanism produces strikingly similar symptoms including muscle weakness, numbness and tingling, fatigue, balance and coordination difficulties, and a chronic course that can include periods of relapse and remission. Both conditions are also diagnosed using some of the same tests, including nerve conduction studies, EMG, and MRI. This overlap makes CIDP one of the more clinically challenging MS mimics to distinguish.

Key Differences Between CIDP and MS

• Location of demyelination: This is the most critical difference. In CIDP, demyelination occurs in the peripheral nerves outside the brain and spinal cord. In MS, demyelination occurs in the central nervous system — the brain and spinal cord. This distinction fundamentally changes the symptom profile, diagnosis, and treatment approach.
• Symptom pattern: CIDP typically causes symmetric, ascending weakness — meaning weakness that is equal on both sides of the body and progresses upward. MS causes a much wider and more varied range of symptoms including vision loss, bladder and bowel dysfunction, and cognitive impairment.
• Age of onset: CIDP typically affects adults in their 30s and 40s. MS is more commonly diagnosed in adults in their 20s and 30s.
• Treatment response: CIDP responds well to corticosteroids, intravenous immunoglobulin (IVIG) therapy, and plasmapheresis. MS is treated with disease-modifying therapies that target the immune system differently. Some MS treatments are not effective for CIDP and vice versa, making an accurate diagnosis essential.

Diagnosis

Diagnosis of CIDP involves a combination of clinical evaluation, nerve conduction studies, EMG, and laboratory tests to rule out other conditions. Spinal fluid analysis may also be performed. Because the symptoms can overlap significantly with MS, the location of nerve involvement — peripheral versus central — is the key factor that distinguishes the two conditions during the diagnostic workup.

Treatment Team

• Neurologists: The primary specialists for CIDP diagnosis and management, ideally with expertise in neuromuscular disorders.
• Physical Therapists: To help maintain strength, mobility, and function.
• Occupational Therapists: To support independence with daily activities affected by weakness and coordination difficulties.
• Primary Care Physicians: For coordinating care and managing general health alongside specialist treatment.

Learn more at the Foundation for Peripheral Neuropathy.

Fibromyalgia is a chronic disorder that causes widespread pain and tenderness in the muscles and soft tissues of the body. It is also associated with fatigue, sleep disturbances, and cognitive difficulties. The exact cause of fibromyalgia is not fully understood, but it is believed to be related to abnormalities in the way the brain and nervous system process pain signals. It can also be triggered by physical or emotional trauma, infections, or autoimmune disorders.

Symptoms of Fibromyalgia

• Widespread pain and tenderness in the muscles, joints, and tendons
• Fatigue, even after adequate sleep
• Sleep disturbances, including difficulty falling or staying asleep
• Cognitive difficulties, including memory problems and brain fog
• Headaches, including tension headaches and migraines
• Irritable bowel syndrome (IBS)
• Sensitivity to light, sound, and temperature
• Depression and anxiety

How Fibromyalgia Mimics MS

Fibromyalgia and MS share several overlapping symptoms that can make them difficult to distinguish, particularly in the early stages. Both conditions cause significant fatigue, cognitive difficulties such as brain fog and memory problems, sensory disturbances including tingling and numbness, sleep disturbances, and mood disorders such as depression and anxiety. Because fibromyalgia has no definitive diagnostic test, it is sometimes misdiagnosed as MS, or vice versa. One of the most important things you can do during this process is learn to rest before you break, because pushing through the diagnostic journey without pacing yourself can make symptoms significantly worse.

Key Differences Between Fibromyalgia and MS

• Cause: Fibromyalgia is thought to be caused by abnormalities in how the brain processes pain signals. MS is an autoimmune disorder in which the immune system attacks the myelin sheath surrounding nerve fibers in the brain and spinal cord.
• Imaging findings: Fibromyalgia produces no lesions on MRI. MS is typically confirmed by the presence of lesions in the brain and spinal cord on MRI.
• Pain pattern: Fibromyalgia is characterized by widespread pain at specific tender points throughout the body. MS does not typically cause this pattern of pain.
• Progression: Fibromyalgia is not a progressive condition and does not lead to permanent neurological damage. MS is progressive and can lead to increasing disability over time.
• Treatment: Fibromyalgia is typically managed through a combination of medication, physical therapy, exercise, and stress reduction. MS is treated with disease-modifying therapies aimed at slowing progression and reducing relapses.

Diagnosis

Fibromyalgia is diagnosed primarily through clinical evaluation and a process of exclusion, ruling out other conditions with similar symptoms. There is no single definitive test for fibromyalgia, which is one of the reasons it is so frequently misdiagnosed. A thorough physical examination, detailed symptom history, and ruling out conditions such as MS, lupus, and thyroid disorders are all part of the diagnostic process.

Treatment Team

Managing fibromyalgia often requires a whole-body approach that goes beyond medication. Alongside working with your care team, eating to support your body with chronic illness can play a meaningful role in managing symptoms and energy levels.

• Rheumatologists: Often the primary specialists for fibromyalgia diagnosis and management.
• Neurologists: May be involved to rule out neurological conditions such as MS.
• Pain Management Specialists: For managing chronic widespread pain.
• Physical Therapists: To help improve muscle strength, flexibility, and reduce pain.
• Mental Health Professionals: To address the depression and anxiety that frequently accompany fibromyalgia.
• Primary Care Physicians: Often the first point of contact and key coordinators of care.

Learn more at the National Institute of Arthritis and Musculoskeletal and Skin Diseases: Fibromyalgia.

MIGRAINES

Symptoms of Migraine

• Moderate to severe throbbing or pulsing headache, often on one side of the head
• Visual disturbances, including aura such as flashing lights, blind spots, or zigzag patterns
• Numbness or tingling in the face, arms, or legs
• Nausea and vomiting
• Sensitivity to light, sound, and smell
• Difficulty speaking or finding words
• Fatigue and cognitive difficulties, including brain fog
• Dizziness and balance problems

How Migraine Mimics MS

Migraines and MS overlap in ways that can genuinely confuse both patients and physicians. Both conditions can cause visual disturbances, numbness and tingling in the limbs, cognitive difficulties, fatigue, dizziness, and difficulty with speech. Perhaps most significantly, both can produce white matter changes on MRI scans, which is one of the primary tools used to diagnose MS. It is this imaging overlap that makes migraines one of the most common reasons for a delayed or incorrect MS diagnosis.

I experienced this firsthand — the first neurologist I saw attributed my symptoms to migraines rather than investigating further. The problem was that migraines only explained part of what I was experiencing. There was a whole constellation of other symptoms that migraines simply could not account for, and it wasn’t until I sought out an MS specialist that the real picture finally emerged. If your symptoms are being attributed to migraines but something feels off, or if migraines don’t seem to explain everything you are experiencing, it is worth asking for a second opinion.

Key Differences Between Migraine and MS

• Primary symptom: The hallmark of migraine is a recurring, often severe headache, frequently accompanied by aura. Headache is not a primary symptom of MS.
• Imaging findings: While both conditions can show white matter changes on MRI, the location, pattern, and characteristics of these lesions differ. MS lesions tend to appear in specific locations such as the periventricular region, corpus callosum, and spinal cord. Migraine-related white matter changes have a different distribution and appearance.
• Course of the disease: Migraines are episodic and do not cause progressive neurological damage. MS is a progressive condition that can lead to increasing disability over time.
• Neurological exam: People with migraines typically have a normal neurological exam between episodes. People with MS often show neurological abnormalities on examination even during periods of remission.
• Treatment: Migraines are managed with pain relief medications, preventive medications, and lifestyle modifications. MS is treated with disease-modifying therapies aimed at slowing progression and reducing relapses.

Diagnosis

Migraine is primarily diagnosed through a detailed clinical history and neurological examination. MRI may be ordered to rule out other conditions, including MS. A headache specialist or neurologist experienced in migraine can help distinguish between migraine-related white matter changes and MS lesions, which is a critical step for anyone who has received conflicting or uncertain imaging results.

Treatment Team

• Neurologists: The primary specialists for migraine diagnosis and management, and for ruling out MS and other neurological conditions.
• Headache Specialists: Neurologists with specific expertise in migraine who can provide more targeted treatment options.
• Primary Care Physicians: Often the first point of contact for migraine management and specialist referrals.
• Ophthalmologists: May be involved when visual disturbances are a significant feature.

Learn more at the American Migraine Foundation.

Acute disseminated encephalomyelitis (ADEM) is a rare neurological disorder that involves sudden and widespread inflammation in the brain and spinal cord. It typically occurs after a viral or bacterial infection, or following a vaccination, as the immune system mounts an unusually aggressive response.

ADEM is one of the more striking entries on this list because of how closely a single episode can resemble a first MS relapse — not just in symptoms, but on MRI. The distinction between the two can be genuinely difficult to make, even for experienced neurologists. ADEM is more common in children than adults, and with treatment, many people recover fully or substantially within a few months. That said, some people who initially present with ADEM go on to develop MS later in life, which makes the follow-up process an important part of the picture.

Symptoms of ADEM

Symptoms often appear suddenly and can progress rapidly over days or weeks. They may include:

• Fever
• Headache
• Nausea and vomiting
• Confusion or altered consciousness
• Seizures
• Weakness, numbness, or tingling in the limbs
• Difficulty with movement or balance
• Visual disturbances

How ADEM Mimics MS

ADEM and MS are two of the most commonly confused neurological conditions because they share the same fundamental mechanism — both involve inflammation and damage to the myelin sheath in the central nervous system. Both can cause weakness, numbness, tingling, balance problems, and visual disturbances. Both show demyelinating lesions on MRI. In some cases, a first episode of ADEM can be virtually indistinguishable from a first MS relapse, which is one of the reasons physicians monitor ADEM patients carefully over time. Importantly, some people who initially present with ADEM go on to develop MS later in life, making the distinction even more nuanced.

Key Differences Between ADEM and MS

• Trigger: ADEM is typically triggered by a recent infection or vaccination, which sets off an immune response that mistakenly attacks myelin. MS is a chronic autoimmune condition with no single triggering event.
• Onset and course: ADEM develops rapidly, often within days to weeks of an infection, and is typically a single episode that resolves with treatment. MS is a chronic condition that develops over time and involves repeated episodes of relapse and remission or progressive worsening.
• Severity of acute symptoms: ADEM tends to cause more severe acute symptoms than a typical MS relapse, including fever, seizures, and altered consciousness — symptoms not commonly associated with MS.
• Age of onset: ADEM is more common in children, while MS is more commonly diagnosed in young to middle-aged adults.
• Prognosis: Most people with ADEM recover fully or substantially with treatment. MS is a lifelong condition with no cure, though disease-modifying therapies can slow its progression.
• Treatment: ADEM is treated with high-dose corticosteroids and supportive care. MS is treated with disease-modifying therapies aimed at reducing relapses and slowing progression.

Diagnosis

ADEM is diagnosed through a combination of clinical history — particularly a recent infection or vaccination — neurological examination, MRI imaging, and analysis of cerebrospinal fluid. Because a single episode of ADEM can look so similar to a first MS relapse on MRI, follow-up imaging over time is often necessary to determine whether the condition is truly ADEM or the beginning of MS.

Treatment Team

• Neurologists: The primary specialists for ADEM diagnosis and management.
• Infectious Disease Specialists: May be involved to identify and treat the underlying infection that triggered ADEM.
• Pediatric Neurologists: For children with ADEM, who represent the majority of cases.
• Physical and Occupational Therapists: To support recovery of movement, coordination, and daily function.
• Primary Care Physicians: For coordinating ongoing monitoring and follow-up care.

Learn more at the National Institute of Neurological Disorders and Stroke: Acute Disseminated Encephalomyelitis.

Myasthenia gravis (MG) is a neuromuscular disorder that causes weakness in the voluntary muscles of the body. It is caused by a breakdown in communication between the nerves and muscles — specifically, the immune system attacks the receptors on muscle cells that receive messages from nerves, disrupting the signals that tell muscles to move.

One of the things that struck me when researching MG is how distinctive its symptoms are once you know what to look for — drooping eyelids, double vision, weakness that gets worse as the day goes on and improves with rest. And yet it still ends up confused with MS often enough to belong on this list. MG affects the muscles that control eye and eyelid movement, facial expression, chewing, swallowing, and speaking, as well as the muscles involved in breathing. With appropriate treatment, most people with MG can manage their symptoms and lead normal or near-normal lives.

Symptoms of Myasthenia Gravis

• Drooping eyelids (ptosis) — one of the most recognizable hallmarks of MG
• Double vision (diplopia) — caused by weakness in the muscles that control eye movement
• Muscle weakness that worsens with activity and improves with rest
• Weakness in the arms, legs, neck, and face
• Difficulty speaking, chewing, and swallowing
• Shortness of breath
• Fatigue that can be severe and interfere with daily activities

Symptoms can vary from person to person and fluctuate over time. It is important to see a doctor if you experience any of these symptoms, as early diagnosis and treatment can significantly improve outcomes.

How Myasthenia Gravis Mimics MS

Both MG and MS are autoimmune disorders in which the immune system mistakenly attacks the body. Both can cause muscle weakness, fatigue, fluctuating symptoms, and difficulty with eye movements and vision — symptoms that overlap significantly enough to cause diagnostic confusion. Both conditions also use some of the same diagnostic tools, including EMG and MRI, and both can follow a relapsing course with periods of exacerbation and improvement. In people whose MG primarily affects the eyes and face in early stages, the overlap with MS can be particularly pronounced.

Key Differences Between Myasthenia Gravis and MS

• Underlying mechanism: MG targets the neuromuscular junction — the point where nerves communicate with muscles — by attacking acetylcholine receptors. MS targets myelin, the protective sheath surrounding nerve fibers in the central nervous system. These are fundamentally different attack sites.
• Hallmark symptoms: Drooping eyelids (ptosis) and double vision that worsen with activity and improve with rest are hallmarks of MG that are not typical features of MS. MS does not characteristically cause these activity-related fluctuations in eyelid or eye muscle function.
• Sensory symptoms: MS commonly causes numbness, tingling, and other sensory disturbances. MG primarily affects motor function and does not typically cause sensory symptoms.
• Age of onset: MG typically affects women in their 20s and 30s and men in their 50s and 60s. MS most commonly affects adults in their 20s and 30s regardless of gender.
• Treatment: MG is treated with acetylcholinesterase inhibitors, immunosuppressive drugs, plasmapheresis, and in some cases removal of the thymus gland. MS is treated with disease-modifying therapies that target the immune system differently.

Diagnosis

Diagnosis of MG involves a physical examination, blood tests for acetylcholine receptor antibodies, and an EMG test to measure electrical activity in the muscles. An ice pack test — applying ice to the eyelid to temporarily improve ptosis — may also be used as a simple bedside diagnostic tool. MRI may be ordered to rule out MS and other central nervous system conditions. Finding a physician experienced in neuromuscular disorders is important, as MG can be complex to diagnose and manage.

Treatment Team

• Neurologists: The primary specialists for MG diagnosis and management, ideally with expertise in neuromuscular disorders.
• Ophthalmologists: For managing eye muscle weakness, drooping eyelids, and double vision.
• Thoracic Surgeons: If thymectomy — removal of the thymus gland — is recommended as part of treatment.
• Pulmonologists: For monitoring and managing breathing difficulties, particularly in more severe cases.
• Physical Therapists: To help maintain strength and function within the limits of the condition.
• Primary Care Physicians: For coordinating care and managing general health.

Learn more at the Myasthenia Gravis Foundation of America.

Finding Your Way to the Right Diagnosis

If there is one thing I hope you take away from this article, it is this: a wrong diagnosis is not the end of the road. It is a frustrating, exhausting, sometimes heartbreaking detour — but it is not the end.

The conditions covered here all share enough symptoms with MS to send even experienced physicians down the wrong path. That is not a reflection of your credibility or your pain. It is a reflection of how genuinely complex neurological diagnosis can be. If you have been dismissed, misdiagnosed, or told your symptoms are all in your head, that experience is real and it matters. Keep advocating for yourself. Keep asking questions. Seek out specialists when you need to. You know your body better than anyone in that exam room.

Getting to the right diagnosis often means understanding not just one condition, but how multiple conditions compare and overlap. If you are still trying to make sense of your symptoms, my chronic illness symptom comparison breaks down how several of these conditions differ from one another in more detail.

And wherever you are in this journey, whether you are newly diagnosed, still searching for answers, or supporting someone you love through this process, you do not have to figure it out alone. That is exactly why this community exists.

It is important to consult with a healthcare provider if you are experiencing symptoms that may be related to MS, as they can help diagnose and differentiate between these conditions.

Frequently Asked Questions

Liked this post? Pin your favorite image for later and share the love!